ong-term Patient Related OuTcomEs in lung Cancer Treatment (PROTECT): Influence of patient decisions on QOL, functionality and survival.
Recruiting
- Conditions
- lung cancer10029107
- Registration Number
- NL-OMON46656
- Lead Sponsor
- Medisch Centrum Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
Newly diagnosed stage III or IV lung cancer, both histopathological proven as clinical diagnosis in patients not able to undergo invasive diagnostics.
Patients must be able to understand and complete protocol requirements, Instructions, and questionnaires provided in Dutch
Exclusion Criteria
First line of cancer treatment for stage III or IV started in another hospital
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary endpoint<br /><br>1) QOL as assessed by questionnaires (QLQ-C30, QLQ-LC13) (sum scores and<br /><br>different subdomains). </p><br>
- Secondary Outcome Measures
Name Time Method